| RS202105428 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS202105574 |
HNF4A
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS202105909 |
RNASET2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic leukoencephalopathy without megalencephaly, Cystic leukoencephalopathy without megalencephaly |
| RS202105931 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS202106192 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Potassium-aggravated myotonia, Congenital myasthenic syndrome 16 |
| RS202106275 |
TMPO
|
Health Risk |
Conflicting classifications of pathogenicity |
Loeys-Dietz syndrome 2, Loeys-Dietz syndrome 2 |
| RS202106463 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, Inborn genetic diseases |
| RS202106628 |
COL18A1
|
Health Risk |
Conflicting classifications of pathogenicity |
COL18A1-related disorder, COL18A1-related disorder |
| RS202107033 |
PDE2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS202107577 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS202107716 |
CAMK2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 53 |
| RS202107738 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Inborn genetic diseases |
| RS202108064 |
AGXT
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary hyperoxaluria, type I |
| RS202108152 |
PLCG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cold autoinflammatory syndrome 3, Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation |
| RS202108457 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic Pulmonary Fibrosis, Dyskeratosis congenita |
| RS202109186 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202109348 |
SLC34A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive hypophosphatemic bone disease, Autosomal recessive hypophosphatemic bone disease |
| RS202109365 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS202109366 |
MESP1
|
Health Risk |
Conflicting classifications of pathogenicity |
MESP1-related disorder, MESP1-related disorder |
| RS202109404 |
PLCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
PLCB1-related disorder, Developmental and epileptic encephalopathy |
| RS202109433 |
ZNF687
|
Health Risk |
Conflicting classifications of pathogenicity |
Paget disease of bone 6, Paget disease of bone 6 |
| RS202109439 |
WDR62
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 2, primary |
| RS202109631 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS202109945 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202109974 |
JAG1
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Cardiovascular phenotype |
| RS202110076 |
PRKDC
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe combined immunodeficiency due to DNA-PKcs deficiency, PRKDC-related disorder |
| RS202110155 |
RECQL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, RECON progeroid syndrome |
| RS202110208 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS202110306 |
HACE1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202110383 |
MTRR
|
Health Risk |
Conflicting classifications of pathogenicity |
Disorders of Intracellular Cobalamin Metabolism, Methylcobalamin deficiency type cblE |
| RS202110519 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS202110635 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Febrile seizures, familial |
| RS202110907 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS202111121 |
SLC30A10
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypermanganesemia with dystonia, polycythemia |
| RS202111347 |
DYNC2I1
|
Health Risk |
Conflicting classifications of pathogenicity |
Short-rib thoracic dysplasia 8 with or without polydactyly, Malignant tumor of esophagus |
| RS202111641 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS202111717 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS202111813 |
NOD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoinflammatory syndrome, Blau syndrome |
| RS202112145 |
LAMC3
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMC3-related disorder, LAMC3-related disorder |
| RS202112771 |
ALG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic liver disease 3 with or without kidney cysts, Familial cystic renal disease |
| RS202112856 |
MKS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS202112906 |
GHSR
|
Health Risk |
Conflicting classifications of pathogenicity |
Short stature due to growth hormone secretagogue receptor deficiency, Short stature due to growth hormone secretagogue receptor deficiency |
| RS202113159 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS202113400 |
DNMT3B
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency-centromeric instability-facial anomalies syndrome 1, Centromeric instability of chromosomes 1 |
| RS202113569 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS202114203 |
IL7R
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 104, Immunodeficiency 104 |
| RS202114467 |
GYS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease due to muscle and heart glycogen synthase deficiency, Glycogen storage disease due to muscle and heart glycogen synthase deficiency |
| RS202114540 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS202114767 |
SLC12A3
|
Health Risk |
Likely pathogenic |
Familial hypokalemia-hypomagnesemia, Inborn genetic diseases |
| RS202115147 |
SORL1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202115157 |
SOX9
|
Health Risk |
Conflicting classifications of pathogenicity |
Camptomelic dysplasia, Camptomelic dysplasia |
| RS202115210 |
FREM1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202115331 |
PRDM16
|
Health Risk |
Pathogenic |
Cardiomyopathy, dilated |
| RS202115635 |
NEK1
|
Health Risk |
Pathogenic; other |
Motor neuron disease, NEK1-related disorder |
| RS202115696 |
NAGLU
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-B |
| RS202115720 |
CEP57
|
Health Risk |
Conflicting classifications of pathogenicity |
Mosaic variegated aneuploidy syndrome 2, Inborn genetic diseases |
| RS202115941 |
LPP
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute myeloid leukemia, Acute myeloid leukemia |
| RS202116866 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2Q, Epidermolysis bullosa simplex with nail dystrophy |
| RS202116993 |
RLBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pigmentary retinal dystrophy, Retinitis pigmentosa |
| RS202117044 |
CPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital hyperammonemia, type I |
| RS202117321 |
KCNA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Atrial fibrillation, familial |
| RS202117532 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 |
| RS202117698 |
PDE11A
|
Health Risk |
Conflicting classifications of pathogenicity |
Pigmented nodular adrenocortical disease, primary |
| RS202118022 |
NDRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease |
| RS202118861 |
CRTAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta |
| RS202119177 |
PRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4F |
| RS202119213 |
CLCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Batten-Turner congenital myopathy, Congenital myotonia |
| RS202119238 |
BICD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures, Inborn genetic diseases |
| RS202119339 |
LAMA5
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, Nephrotic syndrome |
| RS202120144 |
AHNAK2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202120461 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
FG syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS202120583 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS202120615 |
HPS4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS202120684 |
SLC45A2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Oculocutaneous albinism type 4 |
| RS202120786 |
KRIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS202121299 |
POMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Walker-Warburg congenital muscular dystrophy, Autosomal recessive limb-girdle muscular dystrophy type 2K |
| RS202121327 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS202121443 |
NDUFS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 1 |
| RS202121539 |
RERE
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS202121654 |
ANO6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202121941 |
RP1L1
|
Health Risk |
Conflicting classifications of pathogenicity |
Occult macular dystrophy, Inborn genetic diseases |
| RS202121993 |
AHNAK2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202122047 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Dystonia 27 |
| RS202122336 |
PASD1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202122673 |
G6PD
|
Health Risk |
Conflicting classifications of pathogenicity |
Anemia, nonspherocytic hemolytic |
| RS202122911 |
MYH7B
|
Health Risk |
Conflicting classifications of pathogenicity |
MYH7B-related disorder, MYH7B-related disorder |
| RS202123183 |
SERPIND1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202123283 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS202123354 |
TGIF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Holoprosencephaly 4, Holoprosencephaly 4 |
| RS202123650 |
COG5
|
Health Risk |
Conflicting classifications of pathogenicity |
COG5-congenital disorder of glycosylation, COG5-congenital disorder of glycosylation |
| RS202123909 |
CCDC40
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS202124080 |
KCNMA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, idiopathic generalized |
| RS202124189 |
ACADS
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of butyryl-CoA dehydrogenase, Inborn genetic diseases |
| RS202124287 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS202124575 |
GABRG2
|
Health Risk |
Conflicting classifications of pathogenicity |
EPILEPSY, CHILDHOOD ABSENCE |
| RS202124602 |
KIAA0586
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 23, Short-rib thoracic dysplasia 14 with polydactyly |
| RS202125003 |
XDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary xanthinuria type 1, Xanthinuria type II |
| RS202125074 |
PSAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined PSAP deficiency, Krabbe disease due to saposin A deficiency |
| RS202125140 |
ARL13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 8, Inborn genetic diseases |
| RS202125318 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, FG syndrome |